Examkin

Infectious Diseases

502 questions

All types502Multiple choice253Matching131Ordering118
Question 481Question →

An otherwise healthy 54-year-old man is evaluated in the hospital on the third day of his admission for a severe skin infection. He initially presented to the emergency department with diffuse, non-purulent erythema and warmth extending from his left ankle to his knee, along with a temperature of 38.8°C (101.8°F). He was empirically started on intravenous vancomycin and piperacillin-tazobactam.

Today, his temperature is 37.0°C (98.6°F), heart rate is 76/min, blood pressure is 126/78 mmHg, and respiratory rate is 14/min. The area of erythema has receded significantly, and his pain is markedly improved. The patient is conversing comfortably and tolerating a regular diet. Two sets of blood cultures drawn upon admission have both grown *Streptococcus pyogenes* (Group A Streptococcus).

Which of the following is the most appropriate next step in this patient's pharmacotherapy?

Show answer & explanation

Answer: Transition to oral amoxicillin

Answer

Transition to oral amoxicillin.
The correct approach is transitioning to oral amoxicillin. This patient was appropriately started on broad-spectrum intravenous antibiotics (vancomycin for MRSA and piperacillin-tazobactam for Gram-negatives/anaerobes) for severe cellulitis with systemic toxicity. However, by hospital day 3, he is clinically stable, afebrile, and tolerating oral intake. His blood cultures identified Streptococcus pyogenes (Group A Strep), which is universally susceptible to penicillins. Principles of antimicrobial stewardship mandate de-escalating therapy to the narrowest effective agent as soon as the pathogen is identified. Amoxicillin (or Penicillin V) is the ideal narrow-spectrum oral choice for completing therapy.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory and readiness for oral therapy.
The patient is afebrile, hemodynamically stable, demonstrating clinical improvement of the cellulitis, and tolerating a regular oral diet.
These findings fulfill the standard criteria for transitioning a patient from intravenous to oral antimicrobial therapy, allowing for early discharge and minimizing line-associated risks.
2
Analyze the microbiological data to identify the targeted pathogen.
Blood cultures definitively isolated Streptococcus pyogenes (Group A Streptococcus).
Identifying the specific organism allows the clinician to discontinue empiric broad-spectrum coverage designed to treat unknown pathogens (such as MRSA or Pseudomonas).
3
Select the most appropriate narrow-spectrum oral agent based on the pathogen.
Amoxicillin (or penicillin V) is selected.
Group A Streptococcus is universally susceptible to penicillins and does not produce beta-lactamases, making narrow-spectrum beta-lactams the drugs of choice. Amoxicillin is preferred due to excellent oral bioavailability.

Key Concept

In a clinically stable patient with resolving infection and documented Streptococcus pyogenes bacteremia, empiric broad-spectrum intravenous antibiotics should be promptly de-escalated to a narrow-spectrum oral beta-lactam (e.g., amoxicillin or penicillin).
Question 482Question →

A 72-year-old woman with a history of recurrent nephrolithiasis presents to the emergency department with acute right flank pain, rigors, and altered mental status. Her temperature is 39.4°C (102.9°F), blood pressure is 85/50 mm Hg, heart rate is 122/min, and respiratory rate is 24/min. Physical examination reveals pronounced right costovertebral angle tenderness. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: obtain cultures, administer antibiotics and fluids, perform a CT scan, and then consult urology for decompression.
The correct sequence aligns with the Surviving Sepsis Campaign guidelines and principles of surgical source control. Cultures must be drawn first to guide later targeted therapy. This is immediately followed by life-saving medical resuscitation (intravenous fluids and broad-spectrum antibiotics) within the first hour. Once the patient is hemodynamically stable enough for transport, a non-contrast CT scan is performed to confirm the anatomical cause of the urosepsis (an obstructing stone). Finally, with the diagnosis and location confirmed, urology is consulted to perform an emergent decompression, as an infected obstructed kidney is a closed space infection that cannot be cured with antibiotics alone.

Step-by-Step Solution

1
Recognize the clinical presentation as urosepsis with septic shock.
The patient has hypotension, fever, and altered mental status in the setting of suspected pyelonephritis and an obstructing stone.
Identifying septic shock dictates immediate adherence to the Surviving Sepsis Campaign bundle guidelines.
2
Prioritize microbiological testing.
Blood and urine cultures are obtained first.
Drawing cultures before administering antibiotics prevents sterilization of the samples and allows for later de-escalation of therapy.
3
Initiate medical resuscitation.
Intravenous fluids and broad-spectrum antibiotics are administered.
Prompt antimicrobial therapy and restoration of intravascular volume are critical for survival in septic shock and must precede transport to the radiology suite.
4
Perform diagnostic imaging.
A non-contrast CT of the abdomen and pelvis is obtained.
Imaging confirms the diagnosis of an obstructing stone and delineates the anatomy for surgical planning.
5
Establish surgical source control.
Urology is consulted for decompression (e.g., ureteral stenting or percutaneous nephrostomy).
An infected, obstructed kidney is a surgical emergency; intravenous antibiotics cannot adequately penetrate a completely obstructed, purulent collecting system.

Key Concept

The management of urosepsis with suspected obstruction requires a strict clinical sequence: immediate cultures, prompt fluid and antibiotic resuscitation, diagnostic imaging once hemodynamically stable, and emergent urologic decompression for source control.
Estimated Time:1m 30s
Question 483Question →

For each immunocompromised patient described below, pair their clinical presentation with the most appropriate definitive targeted antimicrobial regimen for their suspected or confirmed opportunistic infection.

Click a left item, then click its matching right item

Items

A patient with a CD4 count of 130 cells/mm³, progressive dyspnea on exertion, dry cough, and chest imaging showing bilateral ground-glass opacities.
A patient with a CD4 count of 60 cells/mm³, new-onset seizures, headache, and a brain MRI revealing multiple ring-enhancing lesions in the basal ganglia.
A patient with a CD4 count of 35 cells/mm³, persistent fevers, drenching night sweats, weight loss, and blood cultures growing acid-fast bacilli.
A patient with a CD4 count of 180 cells/mm³, severe retrosternal pain upon swallowing, and endoscopy revealing white, plaque-like lesions throughout the esophagus.

Matches

Show answer & explanation

Answer

The patient with bilateral ground-glass opacities (PCP) is matched with high-dose trimethoprim-sulfamethoxazole. The patient with multiple ring-enhancing lesions (Toxoplasmosis) is matched with pyrimethamine, sulfadiazine, and leucovorin. The patient with systemic symptoms and acid-fast bacilli (MAC) is matched with clarithromycin and ethambutol. The patient with odynophagia and esophageal plaques (Candida esophagitis) is matched with systemic fluconazole.
The correct pairings rely on pattern recognition of classic AIDS-defining illnesses. A CD4 count < 200 with interstitial pneumonia indicates PCP (requires TMP-SMX). A CD4 count < 100 with ring-enhancing brain lesions indicates Toxoplasmosis (requires pyrimethamine and sulfadiazine). A CD4 count < 50 with disseminated symptoms and acid-fast bacilli indicates MAC (requires clarithromycin and ethambutol). Odynophagia with white plaques indicates esophageal candidiasis (requires systemic fluconazole).

Step-by-Step Solution

1
Analyze the CD4 count and clinical syndrome for each patient to identify the specific opportunistic infection.
Identified the pathogens as Pneumocystis jirovecii, Toxoplasma gondii, Mycobacterium avium complex, and Candida albicans, respectively.
Different opportunistic infections predictably manifest when CD4 counts fall below specific thresholds (200, 100, and 50 cells/mm³), creating distinct clinical profiles.
2
Assign the guideline-recommended first-line pharmacotherapy for each identified active infection.
Paired PCP with TMP-SMX, Toxoplasmosis with pyrimethamine/sulfadiazine/leucovorin, MAC with clarithromycin/ethambutol, and Candida esophagitis with fluconazole.
Applying the correct targeted antimicrobial stewardship avoids treatment failure and minimizes inappropriate antibiotic exposure.

Key Concept

Diagnosis and targeted treatment of major HIV-associated opportunistic infections based on clinical presentation and CD4 cell count strata.
Estimated Time:1m 30s
Question 484Question →

During morning rounds on the hematology-oncology unit, a physician evaluates a patient undergoing induction chemotherapy for acute myeloid leukemia. The patient, who is 1212 days into his hospital course, reports the sudden onset of chills overnight. His vital signs include a temperature of 39.1∘C39.1^\circ C (102.4∘F102.4^\circ F), blood pressure of 112/68112/68 mm Hg, pulse of 105105/min, and respirations of 1818/min. Pulse oximetry shows 98%98\% on room air. Detailed physical assessment reveals a clean central venous catheter insertion site with no erythema, tenderness, or exudate. The patient has no oral ulcers, his chest is clear to auscultation, and his skin is fully intact without rashes. Laboratory evaluation is notable for a total leukocyte count of 0.4×1090.4 \times 10^9/L and an absolute neutrophil count of 8080/mm 3^3. Blood and urine cultures have been drawn. Which of the following is the most appropriate initial empiric pharmacotherapy for this patient?

Show answer & explanation

Answer: Intravenous cefepime

Answer

Intravenous cefepime
This patient has high-risk febrile neutropenia, defined as an absolute neutrophil count <500<500/mm 3^3 combined with a single oral temperature ≥38.3∘C\geq 38.3^\circ C (101.0∘F101.0^\circ F) or sustained ≥38.0∘C\geq 38.0^\circ C (100.4∘F100.4^\circ F) for >1>1 hour. Patients undergoing induction chemotherapy for acute leukemia are inherently high-risk due to the expected prolonged and profound duration of neutropenia. The standard of care for high-risk febrile neutropenia without a clinically apparent source is immediate, empiric intravenous therapy with a broad-spectrum antipseudomonal beta-lactam. Cefepime, meropenem, or piperacillin-tazobactam are all appropriate first-line options.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on vital signs and laboratory findings.
The patient has a fever (39.1∘C39.1^\circ C) and profound neutropenia (ANC of 8080/mm 3^3), meeting the criteria for febrile neutropenia.
Febrile neutropenia is an oncologic emergency requiring immediate empiric antimicrobial therapy.
2
Risk-stratify the patient to determine the appropriate setting and route of administration.
The patient is undergoing induction chemotherapy for acute myeloid leukemia, which causes prolonged and profound neutropenia, classifying him as high-risk.
High-risk patients require hospitalization (or continuation of inpatient care) and intravenous antibiotics, whereas low-risk patients may sometimes be managed with oral antibiotics.
3
Select the appropriate antimicrobial spectrum.
An antipseudomonal beta-lactam must be chosen. Because the patient is hemodynamically stable without evidence of pneumonia, skin infection, or catheter-site infection, empiric Gram-positive (MRSA) coverage is unnecessary.
Routine use of vancomycin in all febrile neutropenia cases is contrary to antibiotic stewardship and increases toxicity without improving survival.

Key Concept

Empiric Management of High-Risk Febrile Neutropenia
Estimated Time:1m 15s
Question 485Question →

A 42-year-old man is admitted to the hospital with a 3-day history of high fever, severe chills, and profound fatigue. He has a history of intravenous drug use. His temperature on admission is 39.2°C (102.6°F), blood pressure is 112/68 mm Hg, and pulse is 108/min. Physical examination reveals needle track marks on both antecubital fossae and a new holosystolic murmur at the left lower sternal border that increases in intensity with inspiration. Multiple sets of blood cultures are drawn, and empiric intravenous vancomycin is initiated. A transthoracic echocardiogram confirms a 1.4-cm vegetation on the tricuspid valve. On hospital day 3, the patient is clinically stable, and his temperature has decreased to 37.6°C (99.7°F). Final blood culture reports indicate growth of *Staphylococcus aureus* in 4 out of 4 bottles. Susceptibility testing demonstrates the organism is resistant to penicillin but susceptible to oxacillin, cefazolin, and vancomycin. He has no known drug allergies.

Which of the following is the most appropriate next step in antibiotic management?

Show answer & explanation

Answer: Discontinue vancomycin and initiate intravenous cefazolin

Answer

Discontinue vancomycin and initiate intravenous cefazolin
The correct decision is to discontinue vancomycin and initiate intravenous cefazolin. The patient presents with right-sided infective endocarditis secondary to intravenous drug use. Blood cultures have confirmed Methicillin-Susceptible *Staphylococcus aureus* (MSSA), indicated by susceptibility to oxacillin. For severe MSSA infections, including bacteremia and endocarditis, intravenous antistaphylococcal beta-lactams (such as cefazolin, nafcillin, or oxacillin) are the standard of care. They are strongly preferred over vancomycin because they exhibit more rapid bactericidal activity, which translates into lower rates of clinical failure, relapse, and overall mortality. Proper antibiotic stewardship requires narrowing from broad empiric MRSA coverage to targeted beta-lactam therapy once MSSA is confirmed.

Step-by-Step Solution

1
Analyze the clinical presentation and diagnostic findings.
The patient has a tricuspid valve vegetation and a history of intravenous drug use, confirming a diagnosis of right-sided infective endocarditis.
Establishing the site and severity of the infection dictates the required duration and route of antimicrobial therapy.
2
Interpret the blood culture and susceptibility data.
The pathogen is identified as Staphylococcus aureus that is susceptible to oxacillin and cefazolin, making it Methicillin-Susceptible Staphylococcus aureus (MSSA).
Pathogen identification and susceptibility profiles are critical for transitioning from empiric broad-spectrum therapy to targeted therapy.
3
Select the optimal targeted pharmacotherapy.
The empiric vancomycin must be discontinued and replaced with a targeted intravenous antistaphylococcal beta-lactam, such as cefazolin or nafcillin.
Beta-lactams provide superior bactericidal activity, faster clearance of bacteremia, and significantly improved survival outcomes compared to vancomycin for MSSA infections.

Key Concept

For severe infections caused by Methicillin-Susceptible Staphylococcus aureus (MSSA), such as infective endocarditis, empiric vancomycin should be discontinued and therapy narrowed to an intravenous antistaphylococcal beta-lactam (e.g., cefazolin, nafcillin, or oxacillin) to improve clinical outcomes.
Question 486Question →

A 68-year-old man is brought to the emergency department by his daughter due to a severe, progressive headache, fever, and confusion over the last 24 hours. His temperature is 39.4°C (102.9°F), blood pressure is 110/70 mm Hg, and pulse is 115/min. On physical examination, the patient is lethargic and oriented only to person. Neck stiffness is present with passive flexion. Neurologic examination reveals a new-onset right-sided facial droop and weakness in the right arm. Arrange the following steps in the most appropriate chronological order for the management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, immediately administer empiric antibiotics and dexamethasone, perform a head CT scan to rule out elevated intracranial pressure, and finally perform a lumbar puncture.
In patients with suspected bacterial meningitis, the absolute priority is the rapid initiation of antimicrobial therapy. However, peripheral blood cultures should be drawn first to optimize pathogen recovery. This patient presents with altered mental status and focal neurologic deficits (facial droop, arm weakness), which are strong indications to perform a head CT before a lumbar puncture to rule out an intracranial mass lesion and prevent cerebral herniation. Because obtaining a CT scan takes time, empiric antibiotics (ceftriaxone, vancomycin, and ampicillin for a patient >50 years old) and dexamethasone MUST be administered immediately after blood cultures and before sending the patient to the scanner. Once the CT scan confirms it is safe, the lumbar puncture is performed.

Step-by-Step Solution

1
Evaluate the clinical presentation to establish a working diagnosis.
The triad of fever, neck stiffness, and altered mental status is highly suspicious for acute bacterial meningitis.
Rapid identification of suspected meningitis is necessary because it is a life-threatening neurologic emergency.
2
Assess for 'red flag' indications that require a head CT prior to lumbar puncture.
The patient has a new-onset right-sided facial droop, right arm weakness (focal neurologic deficits), and altered mental status.
Performing a lumbar puncture in the setting of elevated intracranial pressure from a mass lesion can precipitate fatal cerebral herniation.
3
Determine the optimal sequence of interventions considering the need for a CT scan.
Blood cultures must be drawn, followed immediately by empiric antibiotics and dexamethasone. Only then should the patient be sent for a head CT, followed by the lumbar puncture.
Obtaining a CT scan delays the lumbar puncture. Because bacterial meningitis is rapidly fatal, antibiotic administration cannot wait for imaging or cerebrospinal fluid collection.

Key Concept

The sequencing of interventions in suspected bacterial meningitis with indications for neuroimaging prior to lumbar puncture.
Estimated Time:1m 30s
Question 487Question →

A physician is reviewing the microbiological data for a patient in the intensive care unit. The 58-year-old female patient was admitted 6 days ago for severe acute pancreatitis and required immediate endotracheal intubation and mechanical ventilation. On hospital day 4, she developed a temperature of 38.6°C (101.5°F), an increased volume of purulent endotracheal secretions, and worsening oxygenation. A chest radiograph demonstrated a new left lower lobe consolidation. A bronchoalveolar lavage was performed, and the patient was empirically started on intravenous vancomycin and piperacillin-tazobactam for suspected ventilator-associated pneumonia.

Today, the patient's temperature is 37.3°C (99.1°F) and her oxygen requirements have decreased. The bronchoalveolar lavage quantitative culture grows *Escherichia coli* at >105>10^5 colony-forming units/mL. Blood cultures show no growth after 48 hours. The antimicrobial susceptibility profile for the respiratory isolate is as follows:

AntimicrobialSusceptibility
AmpicillinResistant
CefepimeSusceptible
CeftriaxoneSusceptible
MeropenemSusceptible
Piperacillin-tazobactamSusceptible

Based on the culture and susceptibility results, which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Discontinue vancomycin and piperacillin-tazobactam; initiate intravenous ceftriaxone

Answer

Discontinue vancomycin and piperacillin-tazobactam; initiate intravenous ceftriaxone
The correct answer reflects the core principle of antimicrobial stewardship: de-escalation. The patient developed ventilator-associated pneumonia and was appropriately placed on a broad-spectrum empiric regimen (vancomycin and piperacillin-tazobactam). Upon receiving quantitative culture data isolating *Escherichia coli* that is susceptible to ceftriaxone, the clinical imperative is to narrow the spectrum of therapy. Ceftriaxone is a third-generation cephalosporin that provides excellent targeted coverage for this isolate. Discontinuing both vancomycin (as there is no MRSA) and piperacillin-tazobactam (to avoid unnecessary antipseudomonal and anaerobic coverage) minimizes toxicity and prevents the emergence of resistant flora.

Step-by-Step Solution

1
Evaluate the clinical scenario and the diagnosis.
The patient developed ventilator-associated pneumonia (VAP) and was correctly started on empiric broad-spectrum antibiotics (vancomycin for MRSA, piperacillin-tazobactam for Pseudomonas and other Gram-negatives).
Empiric therapy must cover the most likely and dangerous pathogens in the ICU setting until cultures return.
2
Interpret the microbiological culture and susceptibility data.
The culture grew a single pathogen: Escherichia coli. It is resistant to ampicillin but susceptible to ceftriaxone, cefepime, meropenem, and piperacillin-tazobactam. Blood cultures are negative.
Microbiological data allows for the transition from empiric to targeted therapy.
3
Apply antimicrobial stewardship principles to select the definitive therapy.
De-escalate to ceftriaxone.
Once susceptibilities are known, therapy should be narrowed to the most targeted agent. Ceftriaxone is a third-generation cephalosporin that adequately treats the E. coli without providing unnecessary antipseudomonal (piperacillin-tazobactam, cefepime, meropenem), anaerobic (piperacillin-tazobactam, meropenem), or anti-MRSA (vancomycin) coverage.

Key Concept

Antimicrobial De-escalation in Hospital-Acquired Infections
Question 488Question →

A 65-year-old man is evaluated in the hospital on day 3 of admission for community-acquired pneumonia. On presentation, he had a fever, productive cough, and a right lower lobe consolidation on chest radiography. Blood and sputum cultures were obtained, and he was empirically started on intravenous ceftriaxone and oral azithromycin. Today, both blood and sputum cultures are growing Streptococcus pneumoniae. Antimicrobial susceptibility testing reveals the isolate is susceptible to penicillin, amoxicillin, ceftriaxone, and levofloxacin. The patient has improved significantly; his fever has resolved, his cough is much improved, and he is comfortably breathing room air with an oxygen saturation of 97%. He is tolerating a regular diet and mobilizing well. His temperature is 37.1°C (98.8°F), blood pressure is 128/82 mm Hg, pulse is 76/min, and respiratory rate is 16/min. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue the current antibiotics and transition to oral amoxicillin

Answer

Discontinue the current antibiotics and transition to oral amoxicillin
The correct approach for this patient is to discontinue the current empiric antibiotics and begin a targeted, narrow-spectrum oral agent. The patient was admitted with community-acquired pneumonia and initially treated with a standard empiric regimen of ceftriaxone and azithromycin. Blood and sputum cultures have now grown Streptococcus pneumoniae that is susceptible to penicillin and amoxicillin. According to antimicrobial stewardship principles, patients who are clinically stable (afebrile, normalizing vital signs) and able to tolerate oral intake should be transitioned from intravenous to oral therapy. Furthermore, therapy should be narrowed to the most targeted effective agent. Oral amoxicillin is the drug of choice for step-down therapy in penicillin-susceptible Streptococcus pneumoniae infections. Discontinuing azithromycin is also required because empiric atypical coverage is no longer needed once a typical bacterial pathogen is identified.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory and hemodynamic status.
The patient is afebrile, hemodynamically stable, has improving respiratory symptoms, and is tolerating an oral diet.
To determine if the patient meets the criteria for transitioning from intravenous to oral antimicrobial therapy.
2
Review the microbiological culture and susceptibility results.
Cultures confirm Streptococcus pneumoniae that is susceptible to narrow-spectrum beta-lactams (penicillin, amoxicillin).
To identify the definitive pathogen and guide targeted, narrow-spectrum therapy.
3
Select the optimal targeted antimicrobial regimen.
Oral amoxicillin is chosen as the step-down therapy, and atypical coverage (azithromycin) is discontinued.
Antimicrobial stewardship principles require using the narrowest effective agent with the lowest side-effect profile once a pathogen is confirmed.

Key Concept

Patients hospitalized with community-acquired pneumonia who demonstrate clinical stability and have a functioning gastrointestinal tract should be transitioned to a targeted, narrow-spectrum oral antibiotic based on culture susceptibilities.
Question 489Question →

A 26-year-old medical resident sustains a deep percutaneous injury with a hollow-bore needle while drawing blood from a patient. The source patient has a known history of HIV infection and is noncompliant with antiretroviral therapy, with a recent viral load of 150,000 copies/mL. The incident occurs on the medical ward. Arrange the following steps in the most appropriate chronological order for the management of the resident's exposure.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first wash the wound with soap and water, then report to occupational health for baseline serology and risk assessment, followed by initiating a three-drug antiretroviral post-exposure prophylaxis regimen, and finally conducting follow-up HIV serologic testing at 6 weeks, 12 weeks, and 6 months.
The management of an occupational needlestick injury follows a specific chronological protocol to maximize safety and prophylactic efficacy. First, immediate decontamination by washing with soap and water reduces the viral inoculum. Second, the healthcare worker must present to occupational health or the emergency department to document the injury, assess the risk level, and draw baseline serology. Third, based on the high-risk nature of the exposure, a three-drug antiretroviral post-exposure prophylaxis (PEP) regimen is prescribed and must be taken as soon as possible (ideally within 1-2 hours). Finally, because seroconversion may take months, serial follow-up testing is scheduled over a 6-month period.

Step-by-Step Solution

1
Wash the puncture site vigorously with soap and water.
Immediate mechanical reduction of the viral inoculum at the site of injury.
This is the critical first-aid intervention that must be performed locally before seeking formal medical care or leaving the immediate vicinity.
2
Report to occupational health for baseline serology and exposure risk assessment.
Documentation of the exposure, assessment of the risk level, and collection of baseline HIV serology from the exposed worker.
A formal medical evaluation is required to confirm the indication for prophylaxis, select appropriate agents, and establish a pre-exposure baseline.
3
Initiate a three-drug antiretroviral post-exposure prophylaxis regimen.
Systemic prevention of viral replication and integration.
For a high-risk exposure (e.g., hollow-bore needle, high viral load), a 3-drug regimen must be started as soon as possible, ideally within 1 to 2 hours, to maximize efficacy.
4
Conduct follow-up HIV serologic testing at 6 weeks, 12 weeks, and 6 months.
Long-term monitoring for delayed seroconversion.
Baseline testing only demonstrates pre-exposure status; serial testing is required because the window period for seroconversion extends over several months.

Key Concept

The management of high-risk occupational HIV exposure requires a strict sequential approach: immediate local wound decontamination, followed by risk assessment and baseline testing, prompt initiation of a 3-drug post-exposure prophylaxis (PEP) regimen, and structured long-term serologic follow-up.
Question 490Question →

An 82-year-old man residing in a long-term care facility is evaluated during a routine monthly visit. The facility staff report that over the past two days, his urine collection bag has contained visibly cloudy and notably malodorous urine. He has a chronic indwelling urethral catheter that was placed six months ago for severe urinary retention secondary to advanced benign prostatic hyperplasia. The patient currently has no complaints. He denies chills, abdominal discomfort, or flank pain. His appetite is normal, and he has been actively participating in his usual group activities. His temperature is 37.1°C (98.8°F), blood pressure is 130/80 mm Hg, heart rate is 76/min, and respiratory rate is 14/min. Physical examination reveals a soft, non-tender abdomen with no costovertebral angle tenderness. The urethral meatus shows no erythema or purulent discharge. A urinalysis obtained by the staff earlier today demonstrates positive leukocyte esterase, positive nitrites, and 45 leukocytes/hpf. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Observation without antimicrobial therapy

Answer

Observation without antimicrobial therapy
The correct approach is observation without antimicrobial therapy. This patient presents with cloudy, malodorous urine and urinalysis findings consistent with bacteriuria and pyuria. However, he lacks any systemic symptoms (such as fever, rigors, or altered mental status) or localizing signs (such as flank pain or suprapubic tenderness). In patients with a chronic indwelling Foley catheter, bacterial colonization of the bladder and catheter biofilm is ubiquitous and inevitable. Cloudy or foul-smelling urine alone, even with pyuria, is not an indication for testing or treatment in an asymptomatic patient. According to established antibiotic stewardship guidelines, screening for and treating asymptomatic bacteriuria in this population provides no clinical benefit and actively harms the patient by increasing the risk of adverse drug reactions, Clostridioides difficile infection, and the emergence of multi-drug resistant organisms.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient is afebrile, hemodynamically stable, has no localizing signs of infection (no flank or abdominal pain), and is participating in normal daily activities.
Establishing the presence or absence of systemic signs of infection is critical to differentiate asymptomatic bacteriuria from a true urinary tract infection.
2
Evaluate the laboratory findings in the context of a chronic indwelling catheter.
Urinalysis shows pyuria and bacteriuria (cloudy, foul-smelling urine with positive leukocyte esterase and nitrites), which is an expected finding in chronically catheterized patients due to universal biofilm formation and colonization.
Pyuria and malodorous urine do not independently confirm a symptomatic infection in catheterized patients; they merely confirm colonization.
3
Determine the appropriate management based on antibiotic stewardship guidelines.
Because the patient is asymptomatic, the diagnosis is asymptomatic bacteriuria. The standard of care is to avoid antibiotics.
Treating asymptomatic bacteriuria does not improve clinical outcomes and leads to antimicrobial resistance, drug toxicity, and an increased risk of Clostridioides difficile infections.

Key Concept

Management of asymptomatic bacteriuria in chronically catheterized patients
Question 491Question →

Match each clinical scenario requiring targeted antimicrobial prophylaxis with the most appropriate guideline-concordant regimen.

Click a left item, then click its matching right item

Items

A 20-year-old college student who resides in the same dormitory suite as an individual recently hospitalized with confirmed Neisseria meningitidis infection.
A 68-year-old man with a mechanical aortic valve who is scheduled for a routine tooth extraction and periodontal scaling.
A 29-year-old primigravida at 38 weeks gestation presenting in active labor who had a positive rectovaginal swab for Group B Streptococcus at 36 weeks.
A 42-year-old hiker in an endemic region who removes an engorged Ixodes scapularis tick that was attached to the skin for approximately 48 hours.

Matches

Show answer & explanation

Answer

The correct pairings match meningococcal close contacts with single-dose ciprofloxacin, high-risk cardiac patients undergoing dental procedures with pre-procedure amoxicillin, GBS-colonized women in labor with intrapartum IV penicillin G, and high-risk tick bite exposures with single-dose doxycycline.
Each clinical scenario presents a classic indication for prophylactic antimicrobials to prevent severe infectious complications. Meningococcal close contacts require ciprofloxacin, rifampin, or ceftriaxone to eliminate carriage. High-risk cardiac lesions during high-risk dental procedures require amoxicillin to prevent endocarditis. GBS-colonized pregnant women require intrapartum IV penicillin G to protect the neonate. High-risk tick bites require a single prophylactic dose of doxycycline.

Step-by-Step Solution

1
Analyze the meningococcal exposure scenario.
The patient is a close contact (dormitory suite mate), which is an indication for meningococcal prophylaxis.
Close contacts are at high risk of nasopharyngeal carriage and subsequent invasive disease. Prophylaxis with ciprofloxacin eradicates this carriage.
2
Analyze the cardiac patient scenario.
A mechanical valve is a high-risk condition, and tooth extraction involves gingival manipulation, indicating a need for endocarditis prophylaxis.
Procedures manipulating the gingiva can cause transient bacteremia with oral flora. Amoxicillin effectively targets Viridans group streptococci.
3
Analyze the pregnant patient scenario.
Positive GBS screening at 36 weeks with current active labor is a strict indication for intrapartum GBS prophylaxis.
IV Penicillin G administered during labor significantly reduces the risk of vertical transmission and early-onset neonatal sepsis.
4
Analyze the tick exposure scenario.
An engorged Ixodes tick attached for more than 36 hours in an endemic area meets the criteria for Lyme disease prophylaxis.
A single dose of oral doxycycline given within 72 hours of tick removal effectively prevents Borrelia burgdorferi infection.

Key Concept

Indications and regimens for specific antimicrobial prophylaxis (Meningococcal, Endocarditis, Intrapartum GBS, and Lyme disease)
Question 492Question →

A 62-year-old man receiving home total parenteral nutrition for short bowel syndrome is admitted to the hospital with a new-onset fever of 39.2°C (102.6°F) and rigors. His symptoms began shortly after flushing his tunneled central venous catheter at home. His blood pressure is 110/70 mm Hg, heart rate is 105/min, and respiratory rate is 18/min. Physical examination reveals a clean, intact catheter exit site with no erythema or purulence. He has no known drug allergies. The physician suspects a catheter-related bloodstream infection (CRBSI) and formulates a management plan.

Arrange the following clinical interventions in the most appropriate chronological order from the time of patient presentation to the implementation of final definitive therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological management sequence is: 1) Obtain paired blood cultures, 2) Initiate empiric intravenous antibiotics, 3) Remove the central venous catheter, 4) Perform an echocardiogram, and 5) De-escalate to targeted intravenous cefazolin.
The correct sequence mirrors the definitive standard of care for severe healthcare-associated infections. Diagnostics (paired cultures) must universally precede therapeutics (empiric antibiotics). Once the pathogen is identified as S. aureus, source control (catheter removal) becomes the immediate priority. Because S. aureus bacteremia carries a high risk of complicated infection, an echocardiogram is subsequently mandated. Finally, antimicrobial stewardship principles dictate de-escalation from broad-spectrum empiric coverage to definitive targeted therapy (cefazolin for MSSA) once final susceptibilities are available.

Step-by-Step Solution

1
Obtain paired blood cultures from a peripheral vein and the central venous catheter
Pathogen isolation and differential time to positivity calculation.
Blood cultures must be obtained prior to the administration of any antibiotics to ensure accurate identification of the causative organism.
2
Initiate empiric intravenous antibiotic therapy with vancomycin and cefepime
Broad-spectrum coverage of common healthcare-associated pathogens.
Patients with suspected CRBSI require prompt empiric coverage for MRSA and resistant gram-negative organisms to prevent sepsis progression.
3
Remove the central venous catheter upon initial identification of Staphylococcus aureus
Immediate source control.
Unlike coagulase-negative staphylococci, S. aureus CRBSI cannot be safely treated with catheter retention (salvage therapy) due to a high risk of failure and metastatic seeding.
4
Perform an echocardiogram to evaluate for cardiac vegetations
Evaluation for infective endocarditis.
Current guidelines mandate echocardiography for all adult patients with S. aureus bacteremia to rule out endocardial involvement.
5
De-escalate antimicrobial therapy to intravenous cefazolin based on final susceptibility results
Implementation of definitive, targeted therapy.
Once MSSA is confirmed, shifting from vancomycin to an anti-staphylococcal beta-lactam (e.g., cefazolin) is required for optimal bactericidal efficacy and improved survival.

Key Concept

The management of Catheter-Related Bloodstream Infection (CRBSI) and Staphylococcus aureus bacteremia strictly follows a sequence of: pre-antibiotic paired cultures, broad-spectrum empiric therapy, mandatory catheter removal for high-risk pathogens, echocardiographic screening for endocarditis, and ultimate antibiotic de-escalation.
Question 493Question →

A 35-year-old man presents to the emergency department in mid-July with a 4-day history of high fever, severe headache, myalgias, and profound fatigue. He recently returned from a week-long camping trip in the Ozark Mountains of Arkansas. He does not recall any specific insect bites. His temperature is 39.1°C (102.4°F), pulse is 112/min, blood pressure is 118/76 mmHg, and respirations are 18/min. Physical examination reveals a non-toxic appearing man with no skin rashes, nuchal rigidity, or palpable lymphadenopathy. Laboratory studies reveal:

Leukocyte count: 2,400/mm³
Platelet count: 85,000/mm³
Aspartate aminotransferase (AST): 135 U/L
Alanine aminotransferase (ALT): 142 U/L

A peripheral blood smear demonstrates basophilic, intracytoplasmic inclusions within monocytes. Which of the following is the most appropriate pharmacotherapy for this patient?

Show answer & explanation

Answer: Oral doxycycline

Answer

Oral doxycycline
The correct answer is oral doxycycline. This patient's clinical and geographic presentation (summer camping in Arkansas, high fever, myalgias), combined with characteristic laboratory findings (leukopenia, thrombocytopenia, elevated AST/ALT) and pathognomonic peripheral blood smear findings (intracytoplasmic morulae in monocytes), confirms the diagnosis of Human Monocytic Ehrlichiosis (HME). HME is caused by the obligate intracellular bacterium Ehrlichia chaffeensis, transmitted primarily by the Lone Star tick (Amblyomma americanum). Doxycycline is the specific, first-line therapy for HME across all age groups, as it effectively penetrates cells and inhibits bacterial protein synthesis.

Step-by-Step Solution

1
Analyze the patient's epidemiologic and clinical presentation.
The patient has an acute febrile illness, severe headache, and myalgias after a summer camping trip in Arkansas.
The geographic location (Ozarks) and summer season heavily favor exposure to the Lone Star tick (Amblyomma americanum).
2
Evaluate the laboratory findings.
Labs show leukopenia, thrombocytopenia, and elevated transaminases.
These hematological and hepatic findings are classic for Ehrlichiosis and Anaplasmosis, helping to distinguish them from typical bacterial sepsis.
3
Interpret the peripheral blood smear.
The smear shows basophilic, intracytoplasmic inclusions (morulae) within monocytes.
This specific morphological finding confirms the diagnosis of Human Monocytic Ehrlichiosis (HME) caused by Ehrlichia chaffeensis.
4
Select the appropriate pharmacotherapy.
Identify oral doxycycline as the treatment of choice.
Doxycycline effectively penetrates host cells to eradicate obligate intracellular bacteria. Beta-lactam antibiotics are inherently ineffective.

Key Concept

Human monocytic ehrlichiosis (HME) presents with high fever, myalgias, leukopenia, thrombocytopenia, and elevated transaminases. The presence of intracytoplasmic morulae in monocytes is diagnostic, and doxycycline is the definitive, targeted treatment.
Estimated Time:1m 0s
Question 494Question →

Match each clinical presentation requiring targeted or empiric antimicrobial therapy with the most appropriate guideline-concordant oral antibiotic regimen.

Click a left item, then click its matching right item

Items

A 32-year-old pregnant woman (9 weeks gestation) with an expanding, targetoid erythematous rash on her thigh one week after hiking in a wooded area.
A 27-year-old veterinary technician with rapidly progressive pain, swelling, and erythema of the hand 18 hours after a deep puncture wound from a cat.
A 55-year-old man with acute onset of fever and a sharply demarcated, bright red, warm, tender plaque on his lower leg without purulent drainage.
A 38-year-old woman with a 2-day history of frequent bloody stools, severe abdominal cramping, and low-grade fever following a trip to Southeast Asia.

Matches

Show answer & explanation

Answer

The correct matches are: the pregnant patient with Lyme disease requires oral amoxicillin; the cat bite requires oral amoxicillin-clavulanate; the non-purulent cellulitis requires oral cephalexin; and the bloody traveler's diarrhea requires oral azithromycin.
Each clinical scenario presents a distinct infectious syndrome with specific first-line antimicrobial recommendations based on pathogen probability and host factors. The pregnant patient with Lyme disease requires amoxicillin to avoid doxycycline teratogenicity. The cat bite requires amoxicillin-clavulanate for optimal Pasteurella and anaerobe coverage. Non-purulent cellulitis is adequately treated with cephalexin to cover streptococcal species. Severe traveler's diarrhea from Southeast Asia requires azithromycin due to high rates of regional fluoroquinolone resistance.

Step-by-Step Solution

1
Evaluate the pregnant patient with a targetoid rash.
Diagnosis of early localized Lyme disease requiring a teratogen-free regimen.
Doxycycline is contraindicated in pregnancy; amoxicillin is the safe and effective first-line alternative.
2
Evaluate the cat bite wound.
Identification of a high-risk wound requiring coverage for Pasteurella multocida and anaerobes.
Amoxicillin-clavulanate provides the necessary spectrum of activity; standard skin flora antibiotics are inadequate.
3
Evaluate the patient with sharply demarcated leg erythema.
Diagnosis of non-purulent cellulitis (likely Group A Streptococcus).
Cephalexin provides appropriate narrow-spectrum beta-lactam coverage for typical skin infections.
4
Evaluate the patient with bloody traveler's diarrhea from Southeast Asia.
Recognition of high risk for fluoroquinolone-resistant Campylobacter.
Azithromycin is the drug of choice for dysentery acquired in this specific geographic region.

Key Concept

Selection of empiric and targeted antimicrobial therapy requires integrating the most likely pathogen based on the clinical syndrome and exposure history with patient-specific factors such as pregnancy and local resistance patterns.
Question 495Question →

A 22-year-old male college student is brought to the emergency department by his roommate due to a 24-hour history of severe headache, high fever, and progressive confusion. His temperature is 39.4°C (102.9°F), blood pressure is 110/65 mm Hg, pulse is 118/min, and respirations are 22/min. Physical examination reveals marked nuchal rigidity and a positive Brudzinski sign. Funduscopic examination demonstrates blurring of the optic disc margins bilaterally. Which of the following represents the most appropriate chronological sequence of management steps for this patient?

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, immediately follow with empiric intravenous antibiotics and dexamethasone, then perform a non-contrast CT scan of the head, and finally perform a lumbar puncture.
In a patient with suspected bacterial meningitis who exhibits "red flag" indications for a head CT before a lumbar puncture (such as papilledema, focal neurologic deficits, new-onset seizures, severely altered mental status, or an immunocompromised state), the proper sequence prevents life-threatening complications. Blood cultures are drawn first to ensure optimal pathogen recovery. Because the CT scan will delay the lumbar puncture, empiric antibiotics and dexamethasone must be administered immediately after the blood cultures to prevent increased mortality from untreated meningitis. The CT scan is then obtained, and if there is no mass effect, the lumbar puncture is safely performed.

Step-by-Step Solution

1
Identify the clinical syndrome and any high-risk features.
The patient has signs of acute bacterial meningitis along with altered mental status and papilledema.
Recognizing signs of increased intracranial pressure (papilledema, altered mental status) dictates that a head CT is required before a lumbar puncture.
2
Sequence the initial diagnostic step.
Obtain blood cultures.
Blood cultures must be drawn before administering any antibiotics to ensure the highest chance of isolating the causative organism for targeted therapy.
3
Sequence the initial therapeutic step.
Administer empiric intravenous antibiotics and dexamethasone.
Because the lumbar puncture will be delayed by the mandatory CT scan, life-saving antimicrobial therapy must not be withheld and should be given immediately after blood cultures.
4
Sequence the risk-stratification imaging.
Perform a non-contrast CT scan of the head.
Imaging is necessary to evaluate for a space-occupying lesion or midline shift, which are contraindications to lumbar puncture.
5
Sequence the definitive diagnostic test.
Perform a lumbar puncture.
Once the CT scan confirms it is safe, cerebrospinal fluid should be obtained to confirm the diagnosis and guide further targeted therapy.

Key Concept

Management sequence of suspected bacterial meningitis in a patient with signs of increased intracranial pressure.
Question 496Question →

A 54-year-old woman is evaluated in the oncology clinic for a new-onset fever. She is currently receiving induction chemotherapy for acute myeloid leukemia. Yesterday, her temperature was normal, but today she reports a sudden onset of chills and a temperature of 38.8°C (101.8°F). She has no cough, dyspnea, dysuria, abdominal pain, or diarrhea. Vital signs show a blood pressure of 115/75 mm Hg, a pulse of 105/min, and respirations of 16/min. Physical examination reveals a right internal jugular central venous catheter with no surrounding erythema, induration, or purulent drainage. Cardiopulmonary, abdominal, and skin examinations are otherwise unremarkable. Laboratory studies show:

Hemoglobin: 9.2 g/dL
Platelets: 45,000/mm³
Leukocytes: 800/mm³
Neutrophils: 10%
Lymphocytes: 80%
Monocytes: 10%

Blood and urine cultures are obtained. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intravenous cefepime

Answer

Intravenous cefepime
This patient is presenting with febrile neutropenia, an oncologic emergency defined by a single oral temperature of ≥ 38.3°C (101°F) and an absolute neutrophil count (ANC) of < 500/mm³. In this case, the calculated ANC is 80/mm³ (800 leukocytes/mm³ × 10% neutrophils). High-risk patients, such as those with profound neutropenia (ANC < 100/mm³) or those undergoing induction chemotherapy for acute leukemia, require immediate hospitalization and empiric intravenous antibiotics. The initial regimen must provide broad-spectrum coverage against both Gram-positive and Gram-negative organisms, with specific and robust activity against Pseudomonas aeruginosa. Monotherapy with an antipseudomonal beta-lactam, such as intravenous cefepime, meropenem, or piperacillin-tazobactam, is the guideline-concordant appropriate next step.

Step-by-Step Solution

1
Calculate the Absolute Neutrophil Count (ANC).
ANC = Total Leukocytes × (% Neutrophils + % Bands). ANC = 800 × 0.10 = 80/mm³.
To determine if the patient meets the criteria for neutropenia (ANC < 500/mm³ or expected to drop below 500/mm³ within 48 hours).
2
Identify the clinical syndrome.
The patient has a fever of 38.8°C and an ANC of 80/mm³, confirming the diagnosis of febrile neutropenia.
Febrile neutropenia is an oncologic infectious emergency requiring immediate empiric therapy.
3
Stratify the patient's risk level.
The patient is classified as high-risk due to profound neutropenia (ANC < 100/mm³) and undergoing induction chemotherapy for a hematologic malignancy.
Risk stratification determines whether the patient can be treated with oral antibiotics as an outpatient or requires inpatient intravenous therapy.
4
Select the appropriate empiric antimicrobial regimen.
Inpatient therapy with an intravenous antipseudomonal beta-lactam (such as cefepime) is selected.
High-risk febrile neutropenia requires immediate broad-spectrum coverage, particularly against Pseudomonas aeruginosa. Without specific indications like a catheter infection or hemodynamic instability, adding MRSA coverage (vancomycin) is not recommended.

Key Concept

High-risk patients with febrile neutropenia require immediate empiric treatment with an intravenous antipseudomonal beta-lactam (e.g., cefepime, meropenem, or piperacillin-tazobactam). Empiric addition of MRSA coverage is not routinely indicated unless specific risk factors are present.
Question 497Question →

A 62-year-old woman is evaluated in the hospital on hospital day 3. She was initially admitted with fever, chills, severe right flank pain, and dysuria. On admission, her temperature was 39.1°C (102.4°F), heart rate was 112/min, and blood pressure was 105/65 mmHg. Physical examination revealed pronounced right costovertebral angle tenderness. Laboratory studies showed a leukocyte count of 16,500/mm³. Due to a history of an extended-spectrum beta-lactamase (ESBL)-producing *Escherichia coli* urinary tract infection two years ago, she was empirically started on intravenous meropenem. Today, her temperature is 37.1°C (98.8°F), her flank pain has significantly improved, and she is tolerating a regular diet. Blood and urine cultures obtained on admission both grow *Escherichia coli*. Susceptibility testing indicates the isolate is resistant to ampicillin, but susceptible to ceftriaxone, trimethoprim-sulfamethoxazole, ciprofloxacin, and meropenem. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Transition to oral trimethoprim-sulfamethoxazole

Answer

The most appropriate next step in management is to transition the patient to oral trimethoprim-sulfamethoxazole.
The correct answer is to transition the patient to oral trimethoprim-sulfamethoxazole. This patient was appropriately started on empiric intravenous meropenem due to her history of an ESBL-producing organism. However, current cultures demonstrate a non-ESBL *Escherichia coli* strain. Because she has shown significant clinical improvement—being afebrile for at least 24 hours, having resolving symptoms, and tolerating oral intake—she meets the criteria for stepping down from intravenous to oral therapy. Trimethoprim-sulfamethoxazole is highly bioavailable, achieves excellent concentrations in the renal parenchyma, and is a narrower-spectrum agent, making it the ideal choice to complete her treatment course and facilitate hospital discharge.

Step-by-Step Solution

1
Assess the patient's clinical trajectory and current status.
The patient with acute pyelonephritis and bacteremia has shown clear clinical improvement; she is now afebrile, experiencing less pain, and successfully tolerating oral intake.
Clinical stability dictates whether a patient can be safely transitioned from intravenous to oral therapy.
2
Evaluate the microbiology and susceptibility data.
Cultures grew E. coli susceptible to ceftriaxone, TMP-SMX, and ciprofloxacin, indicating that the current infection is not caused by an ESBL-producing strain.
Objective culture data allows for the de-escalation of empiric broad-spectrum coverage to targeted therapy.
3
Select the optimal targeted antimicrobial agent.
Oral trimethoprim-sulfamethoxazole is selected because it is narrow-spectrum, highly bioavailable, and achieves excellent concentrations in the renal parenchyma.
Antimicrobial stewardship requires utilizing the narrowest effective agent via the least invasive route to minimize resistance, reduce side effects, and facilitate hospital discharge.

Key Concept

In patients with acute pyelonephritis who are clinically stable and tolerating oral intake, empiric intravenous antibiotics should be de-escalated to a targeted, highly bioavailable oral agent (such as trimethoprim-sulfamethoxazole or a fluoroquinolone) based on culture susceptibilities.
Estimated Time:1m 15s
Question 498Question →

Match each clinical presentation of an opportunistic infection in a patient with advanced HIV to the most appropriate initial targeted pharmacotherapy regimen.

Click a left item, then click its matching right item

Items

A 34-year-old man presenting with a 2-week history of worsening headache and photophobia; cerebrospinal fluid analysis demonstrates encapsulated yeast cells.
A 41-year-old woman presenting with progressive visual blurring and floaters; funduscopic examination reveals extensive yellow-white retinal infiltrates with associated perivascular hemorrhage.
A 28-year-old man presenting with a 3-week history of dry cough and exertional dyspnea; arterial blood gas shows a PaO2 of 62 mm Hg, and chest radiography reveals diffuse bilateral ground-glass opacities.
A 39-year-old woman presenting with a new-onset generalized tonic-clonic seizure and right-sided hemiparesis; brain magnetic resonance imaging reveals multiple ring-enhancing lesions predominantly in the basal ganglia.

Matches

Show answer & explanation

Answer

The presentation of cryptococcal meningitis pairs with amphotericin B and flucytosine. The presentation of CMV retinitis pairs with valganciclovir. The presentation of severe PCP pairs with trimethoprim-sulfamethoxazole and prednisone. The presentation of toxoplasmic encephalitis pairs with sulfadiazine, pyrimethamine, and leucovorin.
Each clinical scenario describes a classic presentation of a specific opportunistic infection in advanced HIV. The correct antimicrobial regimen must be precisely tailored to the identified pathogen (fungal, viral, or protozoal) and the severity of the disease.

Step-by-Step Solution

1
Identify the underlying opportunistic pathogen for each clinical vignette based on the provided diagnostic clues and physical exam findings.
The vignettes describe cryptococcal meningitis, cytomegalovirus (CMV) retinitis, severe Pneumocystis jirovecii pneumonia (PCP), and toxoplasmic encephalitis, respectively.
Accurate clinical diagnosis of the specific opportunistic infection is the prerequisite for selecting the appropriate targeted antimicrobial therapy.
2
Select the first-line pharmacological regimen indicated for each identified pathogen, accounting for disease severity and required adjunctive therapies.
Cryptococcus requires amphotericin B and flucytosine. CMV requires valganciclovir. Severe PCP requires TMP-SMX with corticosteroids. Toxoplasmosis requires sulfadiazine, pyrimethamine, and leucovorin.
Guideline-directed therapy ensures rapid clearance of the infectious organism, minimizes morbidity, and actively anticipates medication-induced or inflammatory toxicities.

Key Concept

Pharmacotherapy for opportunistic infections in advanced HIV
Question 499Question →

An adult male patient is evaluated during morning rounds on the surgical ward. He is currently on postoperative day 3 following an emergent partial colectomy for a perforated diverticulum. At the time of presentation, he met criteria for sepsis and was empirically started on intravenous meropenem. His clinical course has steadily improved following source control. Today, his temperature is 37.1°C (98.8°F), blood pressure is 122/78 mmHg, and pulse is 76/min. He is tolerating a soft diet, and his bowel function has returned. His white blood cell count has decreased from 18,000/mm³ on admission to 8,500/mm³. Intraoperative peritoneal fluid cultures now demonstrate heavy growth of Escherichia coli and Bacteroides fragilis. Susceptibility testing for the E. coli isolate shows resistance to ampicillin but susceptibility to ciprofloxacin, ceftriaxone, and trimethoprim-sulfamethoxazole. Admission blood cultures have remained sterile. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Transition to oral ciprofloxacin and oral metronidazole

Answer

Transition to oral ciprofloxacin and oral metronidazole
The most appropriate management is transitioning to an oral regimen of ciprofloxacin and metronidazole. The patient has a complicated intra-abdominal infection but has achieved source control and is now clinically stable with a functioning gastrointestinal tract. Antimicrobial stewardship principles strongly emphasize de-escalating from broad-spectrum empiric intravenous therapy (such as meropenem) to a targeted regimen based on culture data. The isolated Escherichia coli is susceptible to ciprofloxacin, and metronidazole provides targeted, highly effective coverage against Bacteroides fragilis. Both agents possess excellent oral bioavailability (approaching 100%), allowing for a safe transition from intravenous to oral therapy. This step-down facilitates the removal of intravenous catheters, minimizes the risk of line-associated complications, and hastens hospital discharge.

Step-by-Step Solution

1
Analyze the patient's clinical trajectory and current status.
The patient is clinically stable, afebrile, and tolerating an oral diet following source control for a complicated intra-abdominal infection.
Determining clinical stability is necessary to decide if a transition from intravenous to oral therapy is safe.
2
Review the microbiological data and required pathogen coverage.
Cultures grew Escherichia coli (susceptible to ciprofloxacin) and Bacteroides fragilis.
Any selected antimicrobial regimen must cover both the aerobic gram-negative rod and the obligate anaerobe.
3
Apply antimicrobial stewardship principles to select the optimal regimen.
De-escalate from empiric meropenem to a targeted, narrow-spectrum regimen. Choose highly bioavailable oral agents (ciprofloxacin and metronidazole) to facilitate prompt intravenous catheter removal.
Stewardship minimizes collateral damage to the microbiome, prevents highly resistant organisms, and reduces hospital-acquired complications like phlebitis or line infections.

Key Concept

Antimicrobial stewardship dictates transitioning from broad-spectrum intravenous therapy to targeted, highly bioavailable oral therapy in clinically stable patients with known culture susceptibilities.
Question 500Question →

During morning rounds, the attending physician reviews the progress of a 71-year-old man who was admitted 4 days ago with shortness of breath, pleuritic chest pain, and a left-sided pulmonary consolidation. The patient was diagnosed with severe community-acquired pneumonia and started on an empiric regimen of intravenous ceftriaxone and azithromycin. Blood cultures collected in the emergency department have yielded *Streptococcus pneumoniae*. Susceptibility testing demonstrates that the organism is highly sensitive to penicillin, amoxicillin, and moxifloxacin, but exhibits resistance to macrolides. The patient has shown marked clinical improvement; he is currently breathing comfortably on ambient air, successfully eating solid meals, and has recorded no temperature elevations for the past 24 hours. His current vital signs show a temperature of 37.0 °C (98.6 °F), blood pressure of 132/82 mm Hg, heart rate of 74/min, and respiratory rate of 14/min. Based on the culture results and clinical status, which of the following is the most appropriate pharmacological management?

Show answer & explanation

Answer: Discontinue current medications and prescribe an outpatient course of oral amoxicillin.

Answer

Discontinue current medications and prescribe an outpatient course of oral amoxicillin.
The correct decision is to transition the patient to oral amoxicillin and arrange for discharge. The patient meets all criteria for transitioning to oral antibiotics: he is hemodynamically stable, afebrile for more than 18-24 hours, has a normal respiratory rate, maintains normal oxygenation on room air, and can tolerate oral intake. Because blood cultures confirmed *Streptococcus pneumoniae* susceptible to penicillin, the principles of antimicrobial stewardship dictate narrowing the treatment spectrum. Amoxicillin is the optimal narrow-spectrum oral agent for penicillin-susceptible *S. pneumoniae*. Discharging the patient minimizes the risk of hospital-acquired complications.

Step-by-Step Solution

1
Evaluate the patient's clinical stability for transition to oral therapy.
The patient is afebrile, hemodynamically stable, breathing comfortably on room air, and tolerating an oral diet.
Patients hospitalized with pneumonia can be safely switched to oral antibiotics and discharged once they achieve clinical stability.
2
Analyze the microbiological data to tailor antimicrobial therapy.
Blood cultures grew Streptococcus pneumoniae that is susceptible to penicillin and amoxicillin, but resistant to macrolides.
Empiric broad-spectrum therapy must be de-escalated to the narrowest effective agent once culture and susceptibility results are available.
3
Select the most appropriate targeted oral antibiotic.
Oral amoxicillin is selected as the step-down therapy.
High-dose oral amoxicillin provides excellent coverage for penicillin-susceptible S. pneumoniae while minimizing collateral damage to the microbiome compared to broader agents like fluoroquinolones or amoxicillin-clavulanate.

Key Concept

Antimicrobial stewardship in community-acquired pneumonia requires transitioning clinically stable patients to targeted, narrow-spectrum oral therapy based on susceptibility data.
PreviousPage 25 / 26Next
Infectious Diseases Practice Questions — USMLE Step 2 CK — Page 25 | Examkin